0001209191-16-096429.txt : 20160208 0001209191-16-096429.hdr.sgml : 20160208 20160208171129 ACCESSION NUMBER: 0001209191-16-096429 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160204 FILED AS OF DATE: 20160208 DATE AS OF CHANGE: 20160208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Janssen Robert CENTRAL INDEX KEY: 0001580849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 161396385 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES STREET 2: 2929 SEVENTH STREET, SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-04 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001580849 Janssen Robert C/O DYNAVAX TECHNOLOGIES 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710 0 1 0 0 Vice President Restricted Stock Unit 2016-02-04 4 A 0 20000 A 2026-02-03 Common Stock 20000 20000 D Option (Right to Buy) 21.99 2016-02-04 4 A 0 80000 A 2023-02-03 Common Stock 80000 80000 D Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units shall vest upon achievement of certain performance conditions. Not applicable. This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter, providing further that the options are subject to approval by our stockholders of an increase in the number of shares available under the 2011 Equity Incentive Plan. Robert Janssen, by /s/ Michael Ostrach, Attorney-in Fact 2016-02-08